- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17:26 | Genentech eliminates 87 jobs in another round of South San Francisco layoffs | ||
| 16:26 | With $550M on the line, Arrowhead reassures investors about pact with troubled Sarepta | ||
| 13:26 | FDA opens national priority fast track, offering 2-month reviews to onshoring and affordability projects | ||
| Di | Scancell picks winner from phase 2 cancer vaccine face-off, choosing next-gen prospect for pivotal trial | ||
| Di | Replimune's shares crater as FDA rejects melanoma drug | ||
| Di | Sanofi tightens grip on RSV, paying $1.15B upfront for Vicebio, boosting its pipeline beyond mRNA | ||
| Mo | Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy | ||
| Mo | iTeos, reeling from TIGT fail, becomes latest prize for deal-hungry Concentra | ||
| Mo | Alkermes reports phase 2 narcolepsy win, advancing challenge to Takeda's blockbuster dream | ||
| Mo | Omega raises $647M for 8th fund aimed at innovative biotechs | ||
| Mo | Roche's COPD drug flunks phase 3 trial, denting hopes of approval this year | ||
| Mo | Cloudbreak sets sights on phase 3 after eye drop passes midstage test | ||
| Mo | Hookipa, having sold off vaccines to Gilead, opts to wind down | ||
| Fr | Flagship's Sail Biomedicines sends staff packing for second time this year | ||
| Fr | 3rd patient dies after receiving a Sarepta gene therapy | ||
| Do | As US cuts research funding, UK plans to invest billions in new biosecurity center | ||
| Do | BioNTech's chief strategy officer Richardson heads for the exit | ||
| Do | I-Mab buys Bridge Health for $3M-plus to strengthen pivot to CLDN18.2 bispecific | ||
| Do | Novartis' B cell-depleting antibody fails to show promise in phase 2 dermatology study | ||
| 16.07. | Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning | ||
| 16.07. | Otsuka inks $613M deal for Swedish biotech's autoimmune antibodies | ||
| 16.07. | Okyo sets sights on first approval in neuropathic eye pain after phase 2 win | ||
| 16.07. | Alphabet's SandboxAQ teams up with Swiss biotech to develop mRNA cancer vaccine | ||
| 16.07. | NIH fires exec amid probe into wife's role in $3.3M contract: report | ||
| 16.07. | Kezar sees hepatitis hold lifted, hints at resurrecting lupus program |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .